Laboratory-based versus non-laboratory-based World Health Organization risk equations for assessment of cardiovascular disease risk

被引:12
|
作者
Dehghan, Azizallah [1 ]
Rayatinejad, Ali [2 ]
Khezri, Rozhan [3 ]
Aune, Dagfinn [4 ,5 ]
Rezaei, Fatemeh [6 ]
机构
[1] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran
[2] Jahrom Univ Med Sci, Student Res Comm, Jahrom, Iran
[3] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran
[4] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England
[5] Oslo New Univ Coll, Dept Nutr, Oslo, Norway
[6] Jahrom Univ Med Sci, Res Ctr Social Determinants Hlth, Jahrom, Iran
关键词
Laboratory-based; Non-laboratory-based; WHO; Cardiovascular disease; Risk prediction; Sensitivity; Specificity; BURDEN; IRAN; COUNTRIES; COHORT;
D O I
10.1186/s12874-023-01961-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundThe WHO model has laboratory-based and non-laboratory-based versions for 10-year risk prediction of cardiovascular diseases. Due to the fact that in some settings, there may not be the necessary facilities for risk assessment with a laboratory-based model, the present study aimed to determine the agreement between laboratory-based and non-laboratory-based WHO cardiovascular risk equations.MethodsIn this cross-sectional study, we used the baseline data of 6796 individuals without a history of cardiovascular disease and stroke who participated in the Fasa cohort study. The risk factors of the laboratory-based model included age, sex, systolic blood pressure (SBP), diabetes, smoking and total cholesterol, while the non-laboratory-based model included age, sex, SBP, smoking and BMI. Kappa coefficients was used to determine the agreement between the grouped risk and Bland-Altman plots were used to determine the agreement between the scores of the two models. Sensitivity and specificity of non-laboratory-based model were measured at the high-risk threshold.ResultsIn the whole population, the agreement between the grouped risk of the two models was substantial (percent agreement = 79.0%, kappa = 0.68). The agreement was better in males than in females. A substantial agreement was observed in all males (percent agreement = 79.8%, kappa = 0.70) and males < 60 years old (percent agreement = 79.9%, kappa = 0.67). The agreement in males >= 60 years old was moderate (percent agreement = 79.7%, kappa = 0.59). The agreement among females was also substantial (percent agreement = 78.3%, kappa = 0.66). The agreement for females < 60 years old, (percent agreement = 78.8%, kappa = 0.61) was substantial and for females >= 60 years old, (percent agreement = 75.8%, kappa = 0.46) was moderate. According to Bland-Altman plots, the limit of agreement was (95%CI: -4.2% to 4.3%) for males and (95%CI: -4.1% to 4.6%) for females. The range of agreement was suitable for both males < 60 years (95%CI: -3.8% to 4.0%) and females < 60 years (95%CI: -3.6% to 3.9%). However, it was not suitable for males >= 60 years (95% CI: -5.8% to 5.5%) and females >= 60 years (95%CI: -5.7% to 7.4%). At the high-risk threshold of 20% in non-laboratory and laboratory-based models, the sensitivity of the non-laboratory-based model was 25.7%, 70.7%, 35.7%, and 35.4% for males < 60 years, males >= 60 years, females < 60 years, and females >= 60 years, respectively. At the high-risk threshold of 10% in non-laboratory-based and 20% in laboratory-based models, the non-laboratory model has high sensitivity of 100% for males >= 60 years, females < 60 years, females >= 60 years, and 91.4% for males < 60 years.ConclusionA good agreement was observed between laboratory-based and non-laboratory-based versions of the WHO risk model. Also, at the risk threshold of 10% to detect high-risk individuals, the non-laboratory-based model has acceptable sensitivity for practical risk assessment and the screening programs in settings where resources are limited and people do not have access to laboratory tests.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations
    Gaziano, Thomas A.
    Pandya, Ankur
    Steyn, Krisela
    Levitt, Naomi
    Mollentze, Willie
    Joubert, Gina
    Walsh, Corinna M.
    Motala, Ayesha A.
    Kruger, Annamarie
    Schutte, Aletta E.
    Naidoo, Datshana P.
    Prakaschandra, Dorcas R.
    Laubscher, Ria
    BMC MEDICINE, 2013, 11
  • [22] Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations
    Thomas A Gaziano
    Ankur Pandya
    Krisela Steyn
    Naomi Levitt
    Willie Mollentze
    Gina Joubert
    Corinna M Walsh
    Ayesha A Motala
    Annamarie Kruger
    Aletta E Schutte
    Datshana P Naidoo
    Dorcas R Prakaschandra
    Ria Laubscher
    BMC Medicine, 11
  • [23] Non-Laboratory-Based Risk Factors for Automated Heart Disease Detection
    Mai, H.
    Pham, T. T.
    Nguyen, D. N.
    Dutkiewicz, E.
    2018 12TH INTERNATIONAL SYMPOSIUM ON MEDICAL INFORMATION AND COMMUNICATION TECHNOLOGY (ISMICT), 2018, : 76 - 81
  • [24] Ten-years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey
    Hanif, Abu Abdullah Mohammad
    Hasan, Mehedi
    Khan, Md Showkat Ali
    Hossain, Md. Mokbul
    Shamim, Abu Ahmed
    Hossaine, Moyazzam
    Ullah, Mohammad Aman
    Sarker, Samir Kanti
    Rahman, S. M. Mustafizur
    Bulbul, Md Mofijul Islam
    Mitra, Dipak Kumar
    Mridha, Malay Kanti
    PLOS ONE, 2021, 16 (05):
  • [25] The Effect of Age on General Cardiovascular Risk Profiles Comparing Laboratory-Based and Non-Laboratory Based Predictors
    Sian, Carr-Lopez M.
    Rajul, Patel A.
    Renae, Minnema
    Joseph, Woelfel A.
    Suzanne, Galal M.
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15
  • [26] Laboratory-based calculation of coronary heart disease risk
    Geberhiwot, T
    Jones, AF
    Bartlett, WA
    Husband, D
    Martin, SC
    CLINICAL CHEMISTRY, 2001, 47 (03) : 589 - 591
  • [27] Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world
    Joseph, Philip
    Yusuf, Salim
    Lee, Shun Fu
    Ibrahim, Quazi
    Teo, Koon
    Rangarajan, Sumathy
    Gupta, Rajeev
    Rosengren, Annika
    Lear, Scott A.
    Avezum, Alvaro
    Lopez-Jaramillo, Patricio
    Gulec, Sadi
    Yusufali, Afzalhussein
    Chifamba, Jephat
    Lanas, Fernando
    Kumar, Rajesh
    Mohammadifard, Noushin
    Mohan, Viswanathan
    Mony, Prem
    Kruger, Annamarie
    Liu, Xu
    Guo, Baoxia
    Zhao, Wenqi
    Yang, Youzhu
    Pillai, Rajamohanan
    Diaz, Rafael
    Krishnapillai, Ambigga
    Iqbal, Romaina
    Yusuf, Rita
    Szuba, Andrzej
    Anand, Sonia S.
    HEART, 2018, 104 (07) : 581 - 587
  • [28] Simple non-laboratory- and laboratory-based risk assessment algorithms and nomogram for detecting undiagnosed diabetes mellitus
    Wong, Carlos K. H.
    Siu, Shing-Chung
    Wan, Eric Y. F.
    Jiao, Fang-Fang
    Yu, Esther Y. T.
    Fung, Colman S. C.
    Wong, Ka-Wai
    Leung, Angela Y. M.
    Lam, Cindy L. K.
    JOURNAL OF DIABETES, 2016, 8 (03) : 414 - 421
  • [29] Who Needs Laboratories and Who Needs Statins? Comparative and Cost-Effectiveness Analyses of Non-Laboratory-Based, Laboratory-Based, and Staged Primary Cardiovascular Disease Screening Guidelines
    Pandya, Ankur
    Weinstein, Milton C.
    Salomon, Joshua A.
    Cutler, David
    Gaziano, Thomas A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (01): : 25 - 32
  • [30] Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE study
    Oliveira, Gustavo Bernardes de Figueiredo
    Nunes, Rafael Amorim Belo
    Alves, Lucas Bassolli de Oliveira
    Neves, Precil Diego Miranda de Menezes
    Sato, Victor Augusto Hamamoto
    Triboni, Ana Heloisa Kamada
    de Oliveira Junior, Haliton Alves
    da Rosa, Priscila Raupp
    Diaz, Maria Luz
    Lopez-Jaramillo, Jose Patricio
    Lanas, Fernando
    Joseph, Philip
    Avezum, Alvaro
    LANCET REGIONAL HEALTH-AMERICAS, 2025, 43